ArticleJTCVS open2026
Left atrial pressure continuous monitoring improves early postoperative outcomes after double-lung transplantation for pulmonary hypertension.
Article in JTCVS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Double-lung transplantation (DLTx) has become the treatment of choice for patients with end-stage pulmonary hypertension (PH). However, DLTx remains a demanding procedure, associated with a greater incidence of severe primary graft dysfunction (PGD) compared with other indications. PH-induced cardiac remodeling includes diastolic left heart dysfunction, which may increase the risk of PGD. We hypothesized that continuous monitoring of left atrial pressure (LAP) could improve early outcomes. Methods: We retrospectively reviewed the chart of patients who underwent DLTx for PH between 2015 and 2022. The use of postoperative LAP monitoring was left to the discretion of the attending transplant surgeon. Results: A total of 135 patients underwent DLTx for PH. Among them, 72 were managed either with prophylactic postoperative extracorporeal membrane oxygenation (ECMO) or with ECMO weaning guided by transesophageal echocardiography and Swan-Ganz catheter, whereas 63 underwent systematic ECMO weaning after the placement of a LAP catheter maintained for 3 to 5 days. Both groups were comparable regarding age, PH diagnoses, and disease severity. The LAP group showed significantly less postoperative ECMO use (25% vs 83%, Conclusions: Continuous postoperative monitoring of LAP after DLTx for PH was associated with improved early outcomes. This strategy may help reduce the incidence of severe postoperative complications in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.